Krsnaa Diagnostics Limited has issued a regulatory disclosure regarding an upcoming board meeting. The meeting of the Board of Directors is scheduled to be held on Monday, November 2, 2026. The primary agenda of the meeting is to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30, 2026.
The disclosure was signed by Sujoy Sudipta Bose, who holds the positions of Company Secretary and Compliance Officer for Krsnaa Diagnostics Limited.